Genomic Health's Revenues Rise 22 Percent; Slashes Loss | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its first-quarter revenues rose 22 percent, while it cut its net loss 58 percent.

The Redwood City, Calif.-based pharmacogenomics test maker brought in total revenues of $41.2 million for the three-month period ended March 31, compared to $33.9 million for the first quarter of 2009. It fell short of analysts' consensus estimate of $43.4 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.